Transient renal failure in a newborn due angiotensin receptor II antagonist use during pregnancy. Report of one case;Efectos sobre la función renal fetal y neonatal del tratamiento con antagonista del receptor de angiotensina II en el embarazo. Caso clínico

Revista Medica de Chile

Volumn 136, Issue 5, 2008, Pages 624-630

  Hasbún H, Jorge ^a,b   Valdés R, Enrique ^a   San Martín O, Alfredo ^a   Catalán M, Jorge ^a   Salinas Q, Soledad ^a   Parra C, Mauro ^a  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^b NONE   (Chile)

Author keywords

Angiotensin II; Kidney failure, acute; Losartan; Renin

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; LOSARTAN;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BLOOD; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; GESTATIONAL AGE; HUMAN; HYPERTENSION; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PREMATURITY; TIME;

ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; CREATININE; FEMALE; GESTATIONAL AGE; HUMANS; HYPERTENSION; INFANT, NEWBORN; LOSARTAN; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREMATURE BIRTH; RENAL INSUFFICIENCY, ACUTE; TIME FACTORS;

EID: 48849104148     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Unith Eight. The Urinary Sistem. In Pansky Ben. Medical Embriology. New York. Macmillan Publishing Co., Inc; 1982; 238-53.
2. SOLBAUG MJ, BOLGER P, JOSE PA. The Developing Kidney and Environmental Toxins. Pediatrics 2004; 113: 1084-91.
3. GALLINI F, LAGGIO L, ROMAGNOLI C. Progression of renal function in preterm neonates with gestational age <32 weeks. Pediatr Nephrol 2000; 15: 119-24.
4. nd ed. Philadelphia (PA): WB Saunders & Company; 1998; 1560-73.
5. LAUDY JA, WLADIMIROFF JW. The fetal lung. 1: Developmental aspects. Ultrasound Obstet Gynecol 2000; 16: 284-90.
6. BOUBRED F, VENDEMMIA M, GARCÍA- MERIC P, BUFFAT C, MILLET V, SIMEONI U. Effects of Maternally Administered Drugs on the Fetal and Neonatal Kidney. Drug Safety 2006; 29: 397-419.
7. ALWAN S, POLIFKA JE, FRIEDMAN JM. Angiotensin II Receptor Antagonist Treatment during Pregnancy. Teratogen Update. Birth Defects Research (Part A) 2005; 73: 123-30.
8. CHEN Y, LASAITIENE D, FRIBERG P. The renin-angiotensin system in kidney development. Acta Physiol Scand 2004; 181: 529-35.
9. DANDREA J, COOPER S, KELLER-WOODS M, BROUGHTON-PIPKIN F, SYMOND ME, STEPHENSON T. The effects of pregnancy and maternal nutrition on the maternal renin-angiotensin system in sheep. Experimental Physiology 2002; 87.3: 353-9.
10. MORGAN T, ROHWASSER A, ZHAO L, HILLAS E, CHENG T, WARD K, LALOUEL JM. Hipervolemia of pregnancy is not maintained in mice chronically overexpressing angiotensinogen. Am J Obstet Gynecol 2006; 195: 1700-6.
11. MORGAN T, CRAVEN C, WARD K. Human Spiral Artery Renin-Angiotensin System. Hipertension 1998; 32: 683-7.
12. NIELSEN AH, SCHAUSER KH, POULSEN K. Current topic: the utero-placental renin-angiotensin system. Placenta 2000; 21: 468-77.
13. SHAH D. Role of the renin-angiotensin system in the pathogenesis of preeclampsia. Am J Physiol Renal Physiol 2005; 614-25.
14. FERRIS T, WEIR E. Effect of Captopril on Uterine Blood Flow and Prostaglandin E Synthesis in the Pregnant Rabbit. J Clin Invest 1982; 71: 809-15.
15. HERSE F, DECHEND R, HARSEM N, WALLUKAT G, JANKE J, QADRI F ET AL. Dysregulation of the Circulating and Tissue-Based renin-Angiotensin System in Preeclampsia. Hypertension 2007; 49: 604-11.
16. SEQUEIRA LÓPEZ MLS, GÓMEZ RA. The role of angiotensin II in kidney embriogenesis and kidney abnormalities. Curr Opinion Nephrol Hypertens 2004; 13: 117-22.
17. BROUGHTON-PIPKIN F, SYMONDS E, TURNER S. The effect of captopril (SQ 14,225) upon mother and fetus in the chronically cannulated ewe and in the pregnant rabbit. J Physiol 1982; 323: 415-22.
18. BROUGHTON-PIPKIN F, WALLACE C. The effect of enalapril (MK421), an antagonist converting enzyme inhibitor, on the conscious pregnant ewe and her foetus. Br J Pharmac 1986; 87: 533-42.
19. KIRK BASS J, FAIX GR. Gestational Therapy with an Angiotensin II Receptor Antagonist and Transient Renal Failure in a Premature Infant. Am J Perinatol 2006 ; 23, 5 : 313-7.
20. SAJI H, YAMANAKA M, HAGIWARA A, IJIRI R. Losartan and fetal toxic effects. Lancet 2001; 357: 363.
21. LAMBOT MA, VERMEYLEN D, NOEL JC. Angiotensin II receptor inhibitors in pregnancy. Lancet 2001; 357: 1619.
22. HINSBERGER A, WINGEN AM, HOYER PF. Angiotensin II receptor inhibitors in pregnancy. Lancet 2001; 357: 1620.
23. AKIL I, INAN S, GURCU B, NAZIKOGLU A, OZBILGIN K, MUFTUOGLU S. Histopathological and ultraestructural effects of Losartan on embryonic rat kidney. Acta Histochemica 2005; 107: 291-300.
24. QUAN A. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Human Development 2006; 82: 23-8.
25. DAIKHA-DAHMANE F, LEVY-BEFF E, JUGIE M, LENCLEN R. Foetal kidney maldevelopment in maternal use of angiotensin II type I receptor antagonists. Pediatr Nephrol 2006; 21: 729-32.
26. COX RM, ANDERSON JM, COX P. Defective embryogenesis with angiotensin II receptor antagonists in pregnancy. Br J Obstet Gynaecol 2003; 110: 1038-40.
27. BALD M, HOLDER M, ZIEGER M, VOCHEM M, LEICHTER HE. Increased renal echogenity in a preterm neonate: Answer. Pediatric Nephrology 2005; 20: 1666-8.
28. KIMBERLY KL. Chemotherapy and pregnancy. Clin Obstet Gynecol 2002; 45: 153-64.
29. DONOSO E , BECKER J, VILLARROEL L. Evolución de la natalidad y del riesgo reproductivo en mujeres de 40 o más años en la década de los 90. Rev Chil Obstet Ginecol 2002; 67: 139-42.
30. HANSSEN M, KEIRSE M, VANKELECOM F, VAN ASSCHE A. Fetal and neonatal effects of treatment with angiotensing-converting enzyme inhibitors in pregnancy. Obstet Gynecol 1991; 78: 128-35.